OCTAPLASLG POWDER

Serial Number 98513154
Registration 7702950
700

Registration Progress

Application Filed
Apr 22, 2024
Under Examination
Approved for Publication
Jan 7, 2025
Published for Opposition
Jan 7, 2025
Registered
Feb 25, 2025

Basic Information

Serial Number
98513154
Registration Number
7702950
Filing Date
April 22, 2024
Registration Date
February 25, 2025
Published for Opposition
January 7, 2025
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 25, 2025
Registration
Registered
Classes
005

Rights Holder

Octapharma AG

03
Address
Seidenstraße 2
Lachen 8853
CH

Ownership History

Octapharma AG

Original Applicant
03
Lachen CH

Octapharma AG

Owner at Publication
03
Lachen CH

Octapharma AG

Original Registrant
03
Lachen CH

Legal Representation

Attorney
Henry B. Ward, III
USPTO Deadlines 2 active
Deadline Type Event Code Deadline Date Days Until Priority Extension Available
MAINTENANCE
Section 8 (6-Year) Declaration Due (Based on registration date 2025-02-25)
R.PRA Feb 25, 2031 2059 days Critical No
MAINTENANCE
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2025-02-25)
R.PRA Feb 25, 2035 3520 days Critical No
Next deadline: Section 8 (6-Year) Declaration Due (Based on registration date 2025-02-25) on February 25, 2031 (2059 days)

Application History

16 events
Date Code Type Description
Feb 25, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 25, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER
Jan 7, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 7, 2025 PUBO A PUBLISHED FOR OPPOSITION
Jan 1, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 12, 2024 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Dec 9, 2024 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 6, 2024 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 6, 2024 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 6, 2024 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 27, 2024 GNRT F NON-FINAL ACTION E-MAILED
Oct 27, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 27, 2024 CNRT R NON-FINAL ACTION WRITTEN
Oct 25, 2024 DOCK D ASSIGNED TO EXAMINER
Apr 22, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 22, 2024 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 005
Pharmaceuticals, namely, Blood plasma preparations

Active Deadlines

Section 8 (6-Year) Declaration Due (Based on registration date 2025-02-25)
Due: Feb 25, 2031
Grace Period Until: Aug 25, 2031
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2025-02-25)
Due: Feb 25, 2035
Grace Period Until: Aug 25, 2035

Classification

International Classes
005

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
POWDER